The following is a summary of “Combining Percentage Prostate-Specific Antigen Reduction and Multiparametric Magnetic ...

Too many men are dying of embarrassment, but there is a game-changer that could save both our lives and our blushes.

Artificial intelligence–derived tumor volume from baseline MRI and postprostatectomy outcomes following neoadjuvant hormonal therapy for patients with high-risk prostate cancer.

Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.

A 66-year-old male patient underwent surgery for prostate cancer 4 years ago. His initial prostate-specific antigen (PSA) ...

The PAIR-1 study shows that the Pi AI software, now in use in NHS and European hospitals, is the first commercial product of ...

The following is a summary of “Computer-aided diagnosis based on 3D deep convolutional neural network system using novel 3D ...

AcuityMD, the intelligence platform for the medical technology (MedTech) industry, has been selected by Profound Medical, a ...

A meta-analysis found that the use of magnetic resonance–guided daily ... with CT-guided non-adaptive SBRT in patients with prostate cancer. In an exploratory analysis, Hispanic men with primary ...

Participants were offered prostate-specific antigen tests and a general health check. Overall, 3,379 men attended a Man Van clinic between January 2023 and January 2024 (nonattendance rate, 15.1%).